MOLECULAR TEMPLATES INC's ticker is MTEM and the CUSIP is 608550109. A total of 65 filers reported holding MOLECULAR TEMPLATES INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $0 | – | 850 | +163.2% | 0.00% | – |
Q1 2023 | $0 | – | 323 | 0.0% | 0.00% | – |
Q4 2022 | $0 | – | 323 | -14.1% | 0.00% | – |
Q3 2022 | $0 | – | 376 | +19.4% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 315 | -86.1% | 0.00% | – |
Q1 2022 | $8,000 | -75.0% | 2,272 | -72.5% | 0.00% | – |
Q4 2021 | $32,000 | -8.6% | 8,259 | +59.3% | 0.00% | – |
Q3 2021 | $35,000 | +66.7% | 5,186 | +97.7% | 0.00% | – |
Q2 2021 | $21,000 | +162.5% | 2,623 | +335.7% | 0.00% | – |
Q1 2021 | $8,000 | +700.0% | 602 | +447.3% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 110 | +120.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 50 | -50.5% | 0.00% | – |
Q1 2020 | $1,000 | -94.7% | 101 | -92.6% | 0.00% | – |
Q4 2019 | $19,000 | +1800.0% | 1,364 | +555.8% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 208 | +73.3% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 120 | +20.0% | 0.00% | – |
Q1 2018 | $1,000 | -96.2% | 100 | -96.2% | 0.00% | – |
Q4 2017 | $26,000 | +44.4% | 2,613 | +3.9% | 0.00% | – |
Q3 2017 | $18,000 | – | 2,514 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 2,052,991 | $1,539,000 | 2.89% |
Kingsbury Capital Investment Advisors LLC | 298,638 | $224,000 | 0.34% |
BVF INC/IL | 4,996,565 | $3,746,000 | 0.16% |
Bellevue Group AG | 11,278,003 | $8,455,000 | 0.12% |
Frazier Life Sciences Management, L.P. | 1,374,047 | $1,030,000 | 0.08% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 528,104 | $396,000 | 0.05% |
Abingworth LLP | 200,000 | $150,000 | 0.05% |
HERBST GROUP, LLC | 10,000 | $7,000 | 0.01% |
Ergoteles LLC | 159,512 | $120,000 | 0.00% |
PICTET ASSET MANAGEMENT SA | 2,903,180 | $2,176,000 | 0.00% |